Biopsy revealed renal cell carcinoma and he underwent a radical nephrectomy.
He subsequently underwent resection of two lesions of the left posterior lung also consistent with renal cell carcinoma.
Serial CT scans in [**2143-9-16**] revealed a solitary left kidney mass of 2 cm and subsequently underwent a left partial nephrectomy.
He was enrolled in a phase III adjuvant trial comparing IL-2 with observation and randomized to the observation arm.
OUTPATIENT MEDICATIONS:  Norvasc 10 mg a day, Zestril 40 mg po q.d., hydrochlorothiazide 25 mg po q.d.
All his hypertensives have been held since [**89**] hours, as well as Tylenol po prn.
He also received his first dose of PEG-Intron at 2 mcg/kg per week equalling a dose of 153 mcg.
He tolerated the two medications without incident.
The Learning Center came and instructed him on the use of subcutaneous injections of IL-2.
